JOLLY ABRAHAM: Open Payments
NPI 1154172906 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $75 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| ABBVIE INC. | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| PhotoniCare Inc | 1 | $17 |
| PFIZER INC. | 1 | $14 |
Products named: MOUNJARO, BREZTRI, VRAYLAR, AIRSUPRA, Ozempic, FANAPT, OtoSight Middle Ear Scope, PAXLOVID.
Industry payments across AZ — which companies pay providers there.
